LPA and myeloid sarcoma: Regarding distribution of subjects with elevated Lp(a) levels, 51.2% (n = 339) presented a diagnosis of MS, in contrast to the proportion of individuals with normal Lp(a) levels: 38.3% (n = 439); P < 0.05.